XML 35 R7.htm IDEA: XBRL DOCUMENT v3.25.4
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
(Accumulated Deficit) Retained Earnings
Accumulated
Other
Comprehensive Loss
Beginning balance (in shares) at Dec. 31, 2023   20,000,000      
Beginning balance at Dec. 31, 2023 $ 9,402 $ 2 $ 0 $ 11,392 $ (1,992)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock in connection with initial public offering, net of underwriting fees and commissions and net of deferred transaction costs of $3,299 (in shares)   6,000,000      
Issuance of common stock in connection with initial public offering, net of underwriting fees and commissions and net of deferred transaction costs of $3,299 102,722 $ 1 102,721    
Conversion of Micron Note into common stock (in shares)   294,217      
Conversion of Micron Note into common stock 5,589   5,589    
Issuance of common stock for share-based award plans (in shares)   2,959,580      
Issuance of common stock for share-based award plans 315   315    
Tax withholding on restricted stock unit settlements (in shares)   (727,182)      
Tax withholding on restricted stock unit settlements (4,575)   (4,575)    
Stock-based compensation expense 26,310   26,310    
Other comprehensive income (loss) (276)       (276)
Net loss for the year $ (39,404)     (39,404)  
Ending balance (in shares) at Dec. 31, 2024 28,526,615 28,526,615      
Ending balance at Dec. 31, 2024 $ 100,083 $ 3 130,360 (28,012) (2,268)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock in a business combination (in shares)   1,101,283      
Issuance of common stock in a business combination 5,266   5,266    
Issuance of common stock for share-based award plans (in shares)   1,697,194      
Issuance of common stock for share-based award plans 899   899    
Tax withholding on restricted stock unit settlements (in shares)   (376,689)      
Tax withholding on restricted stock unit settlements (1,806)   (1,806)    
Stock-based compensation expense 11,417   11,417    
Other comprehensive income (loss) 336       336
Net loss for the year $ (41,206)     (41,206)  
Ending balance (in shares) at Dec. 31, 2025 30,948,403 30,948,403      
Ending balance at Dec. 31, 2025 $ 74,989 $ 3 $ 146,136 $ (69,218) $ (1,932)